First Time Loading...

Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 20.58 USD 2.39% Market Closed
Updated: Apr 30, 2024
Section:
 

Wall Street
Price Targets

FLGT Price Targets Summary
Fulgent Genetics Inc

Wall Street analysts forecast FLGT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FLGT is 27.2 USD with a low forecast of 25.25 USD and a high forecast of 31.5 USD.

FLGT Lowest Forecast
Wall Street Target
25.25 USD
23% Upside
FLGT Average Forecast
Wall Street Target
27.2 USD
32% Upside
FLGT Highest Forecast
Wall Street Target
31.5 USD
53% Upside
Lowest
Price Target
25.25 USD
23% Upside
Average
Price Target
27.2 USD
32% Upside
Highest
Price Target
31.5 USD
53% Upside
Fulgent Genetics Inc Competitors:
Price Targets
K
KLINIQ
Klinique Medical Clinic PCL
22% Upside
AGTI
Agiliti Inc
1% Upside
M
6667
Mega Genomics Ltd
116% Upside
OPCH
Option Care Health Inc
33% Upside
K
KLINIQ
Klinique Medical Clinic PCL
22% Upside
AGTI
Agiliti Inc
1% Upside
M
6667
Mega Genomics Ltd
116% Upside
OPCH
Option Care Health Inc
33% Upside
4694
BML Inc
9% Upside
S
4014
Scientific and Medical Equipment House Company CJSC
10% Downside
D
D
Dental Corporation PCL
8% Upside
V3V
Vita 34 AG
9% Upside

Revenue
Forecast

Revenue Estimate
Fulgent Genetics Inc

For the last 8 years the compound annual growth rate for Fulgent Genetics Inc's revenue is 53%. The projected CAGR for the next 3 years is 7%.

53%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Fulgent Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
22%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Fulgent Genetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

See Also

Summary
FLGT intrinsic value, competitors valuation, and company profile.
DCF Valuation
FLGT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FLGT stock valuation using valuation multiples.
Wall Street Estimates
FLGT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FLGT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FLGT's stock price target?
Price Target
27.2 USD

According to Wall Street analysts, the average 1-year price target for FLGT is 27.2 USD with a low forecast of 25.25 USD and a high forecast of 31.5 USD.

What is Fulgent Genetics Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Fulgent Genetics Inc's revenue is 53%. The projected CAGR for the next 3 years is 7%.

ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.